Illumina’s bid to buy Grail is facing further delays, with EU competition regulators again suspending review of the $8 billion acquisition, MLex has learned.The suspension has not yet been announced, and it is not clear whether it will be backdated, but stopping the clock means that the previous March 25 phase II decision